Vaccination against hepatitis B in patients with chronic renal failure - Twenty years follow-up;Očkování proti virové hepatitidě B u pacientů s chronickým selháním ledvin - Dvacetileté zkušenosti

Vnitrni Lekarstvi

Volumn 57, Issue 10, 2011, Pages 808-814

  Rožnovský, Luděk ^a   Tvrdik J ^b   Kabieszova L ^a   Petrousova L ^a   Orsagova I ^a   Hozakova L ^a   Lochman, I ^c   Kloudova A ^c   Valkovsky I ^a,d   Letocha, P ^e   Schwarzova S ^f   Hladik M ^a   Zjevikova A ^a  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b UNIVERSITY OF OSTRAVA   (Czech Republic)

^c Odbor Imunologie a Alergologie   (Czech Republic)

^d Katedra biomedicínských obor Léka ská fakulta Ostravské univerzity v Ostrav   (Czech Republic)

^e D tské Léka ství M stské Nemocnice Ostrava   (Czech Republic)

^f Vitkovice vyzkum a vyvoj technicke aplikace as   (Czech Republic)

Author keywords

Anti HBs antibodies; HBsAg; Hepatitis B; Renal failure; Vaccine

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; HEPATITIS B ANTIBODY; RECOMBINANT VACCINE;

ARTICLE; CHRONIC KIDNEY FAILURE; CZECH REPUBLIC; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; REVACCINATION; SEROCONVERSION; VACCINATION; ADULT; AGED; BLOOD; IMMUNIZATION; IMMUNOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; VACCINATION; VACCINES, SYNTHETIC; YOUNG ADULT;

EID: 81255198747     PISSN: 0042773X     EISSN: 18017592     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Seaworth B, Drucker J, Starling J et al. Hepatitis B vaccines in patients with chronic renal failure before dialysis. J Infect Dis 1988; 157: 332-337. (Pubitemid 18061247)
2. Gumboš V. Očkovanie pacientov s chronickou obličkovou nedostatočnost'ou proti vírusovej hepatitíde B. Lek Obz 2006; 55: 490-493.
3. Skladaný L', Šváč J, Javorský P et al. Imunizácia proti hepatitíde B u hemodialyzovaných pacientov. Vnitř Lék 1988; 44: 535-537.
4. Jílková E, Jílek D, Bitterová Z et al. Očkování proti virové hepatitidě B u pacientů s chronickým renálním selhání m. Epidemiol Mikrobiol Imunol 1997; 46: 135-139.
5. Fraser GM, Ochana N, Fenyves D et al. Increasing serum creatinine and age reduce the response to hepatitis B vaccine in renal failure patients. J Hepatol 1994; 21: 450-454. (Pubitemid 24308772)
6. Fabrizi F, Dixit V, Messa P et al. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials. J Viral Hepat 2010; doi:10.1111/j.1365-2893.2010.01354.x.
7. Fabrizi F, Dixit V, Messa P et al. Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients. Aliment Pharmacol Ther 2010; 32: 756-762.
8. Are booster immunisations needed for lifelong hepatitis B immunity? European consensus group on hepatitis B immunity. Lancet 2000; 355: 561-565.
9. Bock M, Barros E, Veronese FJ. Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial. Nephrology 2009; 14: 267-272.
10. Tsouchnikas I, Dounousi E, Xanthopoulou K et al. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination. Clin Nephrol 2007; 68: 228-234. (Pubitemid 47527443)
11. Beran J. Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including prehaemodialysis and haemodialysis patients. Expert Opin Biol Ther 2008; 8: 235-247. (Pubitemid 351233716)
12. Miguilena-Colina ME, Lozano-Rodríguez T, García-Pozo L et al. Recombinant inferferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial. Vaccine 2009; 27: 5654-5660.
13. Ramezani A, Eslamifar A, Banifazl M et al. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients. Int J Clin Pract 2009; 63: 394-397.
14. Beran J. Význam druhé generace adjuvantních prostředků v "nových" vakcínách. Klin mikrobiol inf lék 2008; 14: 5-12.
15. Micozkadioglu H, Zumrutdal A, Torun D et al. Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. Ren Fail 2007; 29: 285-288. (Pubitemid 46752340)
16. Morais EO, Resende MR, Oliveira AM et al. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up. Aliment Pharmacol Ther 2007; 25: 849-855. (Pubitemid 46434916)
17. Dow BC, Munro H, Frame D et al. Several assays show hepatitis B positivity soon after vaccination. BMJ 1998; 316: 311. (Pubitemid 28121244)
18. Pazdiora P. Virová hepatitida B na dialyzačních střediscích v ČR. Prakt Lék 1999; 79: 20-22.
19. Dražilová S, Krupicer P, Mogrovičová D et al. Hepatitida B u hemodialyzovaných pacientov. Lek Obz 2009; 57: 145-150.
20. Kong NC, Beran J, Kee SA et al. A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int 2008; 73: 856-862. (Pubitemid 351398279)
21. Sali S, Alavian SM, Hajarizadeh B. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients. Nephrology 2008; 13: 376-379.